Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jessica A. Meurer"'
Autor:
Jeffrey W. Clark, Lauren Matlack, Sanya Arshad, Ryan B. Corcoran, Aparna Raj Parikh, Benjamin D. Greenbaum, Colin D. Weekes, Michael J. Raabe, Lorraine C. Drapek, Jon Dubois, Theodore S. Hong, David P. Ryan, David T. Ting, Lipika Goyal, Bronwen Foreman, Bruce J. Giantonio, Leilana Ly, Hannah Thel, Arnav Mehta, Lawrence S. Blaszkowsky, Nir Hacohen, Andrew X. Zhu, Jennifer Y. Wo, David Hoyos, Ryan D. Nipp, Emily E. Van Seventer, Jill N. Allen, Annamaria Szabolcs, Jessica A. Meurer, David J. Lieb, Beow Y. Yeap
Publikováno v:
Nature Cancer. 2:1124-1135
Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable (MSS) colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) remains challenging. We conducted a single-arm, non-randomized, phase II trial (NCT03104
Autor:
Beow Y. Yeap, Bronwen Foreman, David Hoyos, Nir Hacohen, Sanya Arshad, Jennifer Y. Wo, Lauren Matlack, Jon Dubois, Benjamin Greenbaum, Colin D. Weekes, David P. Ryan, David J. Lieb, Lawrence S. Blaszkowsky, Ryan D. Nipp, Arnav Mehta, Leilana Ly, Emily E. Van Seventer, Annamaria Szabolcs, Jill N. Allen, Jessica A. Meurer, Lorraine C. Drapek, Jeffrey W. Clark, Andrew X. Zhu, Ryan B. Corcoran, Lipika Goyal, Bruce J. Giantonio, Hannah Thel, Theodore S. Hong, David T. Ting, Aparna Raj Parikh
Immune checkpoint blockade has limited efficacy in microsatellite stable (MSS) colorectal (CRC) and pancreatic (PDAC) cancer. Preclinical models have demonstrated the use of radiation to activate the innate immune response and stimulate responsivenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e56b0a1948d63053def5275a1df4e7f
https://doi.org/10.21203/rs.3.rs-58489/v1
https://doi.org/10.21203/rs.3.rs-58489/v1
Autor:
Aparna R, Parikh, Annamaria, Szabolcs, Jill N, Allen, Jeffrey W, Clark, Jennifer Y, Wo, Michael, Raabe, Hannah, Thel, David, Hoyos, Arnav, Mehta, Sanya, Arshad, David J, Lieb, Lorraine C, Drapek, Lawrence S, Blaszkowsky, Bruce J, Giantonio, Colin D, Weekes, Andrew X, Zhu, Lipika, Goyal, Ryan D, Nipp, Jon S, Dubois, Emily E, Van Seventer, Bronwen E, Foreman, Lauren E, Matlack, Leilana, Ly, Jessica A, Meurer, Nir, Hacohen, David P, Ryan, Beow Y, Yeap, Ryan B, Corcoran, Benjamin D, Greenbaum, David T, Ting, Theodore S, Hong
Publikováno v:
Nature cancer. 2(11)
Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable (MSS) colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) remains challenging. We conducted a single-arm, non-randomized, phase II trial (NCT03104
Autor:
Beow Y. Yeap, Aparna Raj Parikh, Jennifer Y. Wo, Lawrence S. Blaszkowsky, A A Bannon, Jeffrey W. Clark, Jill N. Allen, Lorraine C. Drapek, Theodore S. Hong, Jessica A. Meurer, David P. Ryan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e81
Purpose/objective(s) SBRT for liver metastases has emerged as a viable option for treatment of unresectable liver metastases. Among patients with colorectal cancer, however, recent phase II data demonstrated a 1-year local control of 60%, suggesting